differentiation

A unique collection of 1197 stem cell differentiation signaling targeted compounds for high throughput and high content screening;

A unique collection of 573 cancer cell differentiation inducing compounds for high throughput and high content screening;

672 compounds related to neuronal differentiation, suitable for the drug development of nervous system disease.

A collection of 17100 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification;

A unique collection of 4533 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screen

A unique collection of 263 kinase inhibitors regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening.

A unique collection of 1810 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 237 Wnt Hedgehog Notch signaling targeted compounds for high throughput and high content screening;

A unique collection of 3404 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 800 natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 2080 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies；

A collection of 25682 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification.

A unique collection of 2771 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs;

A unique collection of 365 compounds targeting MAPK signaling for drug discovery in MAPK related diseases;

128 methylation-related compounds that can be used for high-throughput and high-content screening.

Detialed biological information and pharmacological information of the products, providing theoretical direction and research basis for screening.

A unique collection of 184 TGF-beta Smad signaling targeted compounds for high throughput and high content screening;

A unique collection of 317 osteogenesis related compounds for high throughput and high content screening;

A unique collection of 693 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS);